SCD and nonpapillary renal cell carcinoma: A previous study showed that increased SCD1 expression supported ccRCC viability, and when SCD1 was blocked using the small molecule inhibitor A939572, a significantly reduced cancer cell proliferation and the induction of apoptosis were observed [41].